[Home ] [Archive]    
:: Volume 16, Issue 5 (November & December 2011 2011) ::
pajoohande 2011, 16(5): 234-240 Back to browse issues page
Evaluation of knocking down of the RNAi mediated gamma globin repressor into K562 cells, for gene therapy of beta-thalassemia
Ali Mohammad Asgharian *, Mehdi Banan, Hossein Najmabadi
Instructor, Department of Cell and Molecular Biology, Tonekabone Branch, Islamic Azad University, Tonekabone, Iran , mehranasgharian@yahoo.com
Abstract:   (8341 Views)
Background and Aim: Beta-thalassemia is a genetic disorder manifested by the presence of anemia in adult patients. One approach to treatment of beta-thalassemia is induction of the fetal gamma-globin gene. One of the gamma-globin repressors is a complex called DRED (Direct repeat erythroid-definitive). DRED is composed of TR2 and TR4 DNA binding subunits. The aim of this study was to set up the RNAi system to increase the expression of the gamma-globin gene. Materials and Methods: In this study, lipofectaminTM2000 was used to transfect siRNA molecules and pSV-β-Galactosidase vector was used as a reporter to monitor transfection efficiency. Real-time PCR method was used to measure TR4 knockdown and gamma-globin expression levels. Results: Our findings showed that K562 cells were transfected by 40% using LipofectamineTM 2000. Also, the level of TR4 expression decreased by 44% after using TR4siRNA, even though the expression of gamma-globin gene was induced by 1.18 times. ‍Conclusion: Despite a 44% knockdown of TR4, no increase in gamma-globin mRNA was observed. Two factors may count for this observation first, TR4 knockdown may have been limited by our transfection efficiency. Second, simultaneous knockdown of TR2 and TR4 may lead to increased gamma-globin levels. In conclusion, although knocking down of TR4 expression occurred by using RNAi system, this can not be a solitary efficient way to induce the gamma-globin expression.
Keywords: beta-Thalassemia, TR4 siRNA, TR4 inhibition, gamma-Globins, K562 Cells
Full-Text [PDF 329 kb]   (2231 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ali Mohammad Asgharian, Mehdi Banan, Hossein Najmabadi. Evaluation of knocking down of the RNAi mediated gamma globin repressor into K562 cells, for gene therapy of beta-thalassemia. pajoohande. 2011; 16 (5) :234-240
URL: http://pajoohande.sbmu.ac.ir/article-1-1207-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 5 (November & December 2011 2011) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4374